UPDATE | July 30, 2026

Controlling complexity in ADC formulation development

  • MAIL

Controlling Complexity in ADC Formulation Development


Antibody-drug conjugates (ADCs) present formulation challenges that extend beyond those of conventional monoclonal antibodies. Conjugation influences molecular stability throughout development, requiring formulation strategies tailored to the characteristics of each molecule.


This whitepaper explores how Samsung Biologics approaches ADC formulation development by integrating analytical characterization, formulation development, and process considerations to support more robust manufacturing outcomes.


Key highlights include:
  • How conjugation influences critical stability attributes and drives molecule-specific formulation strategies

  • Considerations for buffer selection, excipient screening, process-stress studies, lyophilization development, and photostability assessment

  • Strategies for identifying formulation vulnerabilities early and connecting analytical insights to process controls


Discover how an integrated approach to ADC formulation development can support more robust development and manufacturing.

Controlling Complexity in ADC Formulation Development


Antibody-drug conjugates (ADCs) present formulation challenges that extend beyond those of conventional monoclonal antibodies. Conjugation influences molecular stability throughout development, requiring formulation strategies tailored to the characteristics of each molecule.


This whitepaper explores how Samsung Biologics approaches ADC formulation development by integrating analytical characterization, formulation development, and process considerations to support more robust manufacturing outcomes.


Key highlights include:
  • How conjugation influences critical stability attributes and drives molecule-specific formulation strategies
  • Considerations for buffer selection, excipient screening, process-stress studies, lyophilization development, and photostability assessment
  • Strategies for identifying formulation vulnerabilities early and connecting analytical insights to process controls


Discover how an integrated approach to ADC formulation development can support more robust development and manufacturing.

Share article

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required